SPOTLIGHT -
Molecular Testing Mainstays for Acute Myeloid Leukemia
Navel G. Daver, MD, discusses the molecular characteristics of acute myeloid leukemia, agents available for the treatment of mutated acute myeloid leukemia, and how to potentially improve treatment in the future.
Read More
Evolving Treatments Address Challenging AML Subtypes
In an interview with Targeted Oncology, Richard M. Stone, MD, discussed challenging subtypes of acute myeloid leukemia and therapies available to treat them.
The Evolving Disease Managing Patterns in Acute Myeloid Leukemia
Rajneesh Nath provides an expert's take on the evolution of risk stratification, molecular testing, and treatment of acute myeloid leukemia.
